Valeo Pharma Inc
TSX:VPH
Valeo Pharma Inc
TSX:VPH
Price:
0.105 CAD
5%
Market Closed
Updated:
May 21, 2024
P/E
Price to Earnings
Price to Earnings
-0.4
Current
-1.9
Median
20
Industry
Higher
than median
Lower
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=-0.4
Market Cap
/
10.4m
Net Income
-28.4m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| CA |
|
Valeo Pharma Inc
TSX:VPH
|
10.4m CAD | -0.4 | |
| CA |
A
|
Advance Lithium Corp
XTSX:AALI
|
517.8B CAD | -143 509.4 | |
| US |
G
|
Gould Investors LP
OTC:GDVTZ
|
303.5B USD | 0 | |
| US |
C
|
Carson Energy Development Corp
OTC:CDVM
|
270.6B USD | -70 424.1 | |
| NL |
N
|
Nepi Rockcastle NV
JSE:NRP
|
77.4B Zac | 0 | |
| US |
|
Liberty Bancshares Inc
OTC:LBSI
|
55.5B USD | 0 | |
| US |
|
Ergo Science Corp
OTC:ERGN
|
55.2B USD | -12 841.6 | |
| US |
H
|
HK Graphene Technology Corp
OTC:HKGT
|
53.9B USD | -33 104.9 | |
| ID |
|
Amman Mineral Internasional Tbk PT
IDX:AMMN
|
765.1T IDR | 43.9 | |
| US |
G
|
GE Vernova LLC
NYSE:GEV
|
44.1B USD | 0 | |
| US |
|
Coupang Inc
F:788
|
38.4B EUR | 32.7 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
-0.5
2-Years Forward
P/E
-0.8
3-Years Forward
P/E
N/A
You don't have any saved screeners yet
